Skip to main content
PCI Biotech Holding ASA (FRA:4QG)
Germany flag Germany · Delayed Price · Currency is EUR
0.0180
0.00 (0.00%)
At close: Dec 5, 2025

PCI Biotech Holding ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-20.54-16.42-20.32-55.1-88.39-72.24
Upgrade
Depreciation & Amortization
0.450.30.370.632.542.21
Upgrade
Asset Writedown & Restructuring Costs
---5.77--
Upgrade
Stock-Based Compensation
1.150.831.96-1.2912.946.34
Upgrade
Other Operating Activities
0.070.060.05-0.122.57-8.45
Upgrade
Change in Accounts Receivable
-1.27-1.273.596.040.961.48
Upgrade
Change in Accounts Payable
1.011.010.22-3.25-1.45-3.41
Upgrade
Change in Other Net Operating Assets
3.311.73-0.84-11.732.52-3.32
Upgrade
Operating Cash Flow
-15.82-13.76-14.97-59.04-68.31-77.39
Upgrade
Capital Expenditures
-0.63----0.34-3.92
Upgrade
Investing Cash Flow
-0.63----0.34-3.92
Upgrade
Long-Term Debt Repaid
--0.36-0.44-0.68-0.67-0.67
Upgrade
Net Debt Issued (Repaid)
-0.47-0.36-0.44-0.68-0.67-0.67
Upgrade
Issuance of Common Stock
-----0.32
Upgrade
Financing Cash Flow
-0.47-0.36-0.44-0.68-0.67-0.35
Upgrade
Foreign Exchange Rate Adjustments
---0.2-2.538.53
Upgrade
Miscellaneous Cash Flow Adjustments
0---0-
Upgrade
Net Cash Flow
-16.92-14.12-15.41-59.52-71.85-73.14
Upgrade
Free Cash Flow
-16.45-13.76-14.97-59.04-68.65-81.31
Upgrade
Free Cash Flow Margin
-350.83%-204.28%-500.67%-1242.99%-1094.34%-1103.56%
Upgrade
Free Cash Flow Per Share
-0.44-0.37-0.40-1.58-1.84-2.18
Upgrade
Cash Interest Paid
--00.050.2-
Upgrade
Levered Free Cash Flow
-9.55-8.62-9.12-44.95-36.62-50.26
Upgrade
Unlevered Free Cash Flow
-9.48-8.58-9.02-44.87-36.56-50.01
Upgrade
Change in Working Capital
3.051.472.97-8.942.04-5.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.